Biotech · Private company · Lexington, MA, US
Protean Bio Inc.
Track this companyFree. Adds Protean Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- IND-enabling studies of D6PV- a novel ApoC-II peptide mimetic therapeuticFiscal year 2026 · $999.4KNIH RePORTER 5R44DK135188-04 · fetched Nov 12, 2026
- IND-enabling studies of D6PV- a novel ApoC-II peptide mimetic therapeuticFiscal year 2025 · $999.8KNIH RePORTER 2R44DK135188-03A1 · fetched Nov 12, 2026
- Development of D6PV- a novel ApoC-II peptide mimetic therapeuticFiscal year 2024 · $997.7KNIH RePORTER 5R44DK135188-02 · fetched Nov 12, 2026